Scholars Central

Conference abstractPublished 8 Sep 2014

Risk based intercultural property assessment

Authors: Jerry Xu

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

IP protection is of paramount importance in the pharmaceutical industry, particularly during outsourcing. As a leading CRO, we are working very hard to quantitatively identify the IP gaps in our GMP practices so they can be managed accordingly. In this presentation, principles from ICH Q9 to assess the integrity of our IP system, and some of the weakness we see and the challenges we face to improving IP in GMP area at WuXi Apptec, a major contract research organization (CRO) in China (Asia) will be discussed. A methodology implemented that may be useful to others in the industry as well to assess their IP status will also be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jerry Xu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels